首页>
外国专利>
PAX2 AND PAX8 AS TARGETS FOR IMMUNOLOGIC AND MOLECULAR TUMOUR TREATMENT STRATEGIES
PAX2 AND PAX8 AS TARGETS FOR IMMUNOLOGIC AND MOLECULAR TUMOUR TREATMENT STRATEGIES
展开▼
机译:PAX2和PAX8作为免疫和分子肿瘤治疗策略的目标
展开▼
页面导航
摘要
著录项
相似文献
摘要
Briefly, the present invention refers to the transcription factors PAX2 and PAX8 expressed in solid tumours and haematologic malignancies, and their utility as a target in immunotherapy and molecular therapy. In more detail, the invention refers to a method for identifying an immunogenic T-cell epitope from PAX2 and/or PAX8. Furthermore, the invention refers to a use of immunogenic T-cell epitopes, e.g. identified by said method, and their use as targets for the recognition by targeting means, e.g. T-cells or antibodies. The invention also refers to peptides representing immunogenic T-cell epitopes and their uses for the preparation of a pharmaceutical composition for immunotherapy of PAX2 and/or PAX8 expressing malignancies.
展开▼